Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06165653

Guided Meditation During Radiation Therapy for Brain Tumors

The goal of this interventional treatment study is to assess the anxiolytic effect of providing guided meditation during radiation treatment (RT) in patients with brain tumors.

The main question it aims to answer is:

• What is the change in acute anxiety in participants receiving the mindfulness intervention during radiation therapy compared to standard of care control conditions?

Participants will be asked to participate in a 5-minute, audio-recorded mindfulness practice that will be played during the administration of each RT session. Researchers will compare this intervention to standard of care (no intervention) during RT.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Huntsman Cancer Institute

Salt Lake City, Utah, 84112, United States

Location status: Recruiting

Location contact

Rachel Kingsford

CONTACT

[email protected]

801-585-0115

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participant aged ≥ 18 years.
  • Radiologically confirmed tumor of the brain. Note: Participants may have tumor resected after diagnosis.
  • Eligible to undergo radiation treatment for brain tumor for 25-33 treatments.
  • Willing to participate in either the guided meditation or standard of care control arm, regardless of treatment assignment.
  • Karnofsky performance score ≥ 60 or ECOG performance score ≤ 2.
  • MoCA mini score ≥ 11
  • Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines.

Exclusion criteria

  • Active suicidal ideation or active psychotic state in the opinion of the investigator.
  • An unstable illness that, in the opinion of the investigator, would interfere with study treatment.
  • Prior radiation therapy to the brain.
  • Inability to understand and/or speak the English language.

Treatment and study plan

10 to 15-Minute, Audio-Recorded Guided Mediation Practice

Behavioral

Five different meditation practices will be provided, all of which have been validated in prior research.

  • The Body Scan practice consists of instruction in how to direct non-judgmental attention to different regions of the body
  • The Mindful Breathing practice consists of focused attention on the breath and metacognitive monitoring and acceptance of discursive thoughts, negative emotions, and body sensations
  • The Mindfulness of Discomfort practice consists of instruction in how to "zoom in" to deconstruct discomfort and map each feelings' spatial location, use mindful breathing to "zoom out" and broaden the field of awareness to include neglected sensory elements, and shift attention from unpleasant feelings to neutral/pleasant sensations or experiences
  • The Savoring practice consists of instruction in identifying and amplifying pleasant memories
  • The Loving-Kindness practice consists of instruction in cultivating feeling of warmth and compassion toward the self and others

Primary outcomes

  1. Change in acute anxiety, measured by score on individual item derived from GAD-2, in participants receiving mindfulness intervention during RT compared to standard of care control conditions.

    Time frame: 7 weeks

    To assess the acute anxiolytic effects of a brief mindfulness intervention during RT for brain tumor patients with mask anxiety.

    Acute anxiety during RT will be measured each RT visit with an individual item ("How nervous, anxious or on edge do you feel right now?" scored on a 0-10 scale) derived from the Generalized Anxiety Disorder 2-item (GAD-2) scale, "0" meaning "Not at All" and "10" meaning "Very Much") measured before and after RT. The change from before to after RT will be averaged over all RT visits.

Secondary outcomes

  1. Change in anxiety in everyday life in participants receiving mindfulness intervention during RT compared to standard of care, measured using the total score of the GAD-2 scale prior to RT

    Time frame: 7 weeks

    To assess the distal anxiolytic effects of a brief mindfulness intervention during RT for brain tumor patients with mask anxiety.

    Anxiety in everyday life will be measured using the total score of the Generalized Anxiety Disorder 2-item (GAD-2) scale prior to RT (minumum value 0, maximum value 6, score of 3 or higher considered clinical.) This will be measured once a week during RT.

  2. Change in anxiety during RT and in everyday life as measured by the modified MPoD

    Time frame: 7 weeks

    To determine whether the brief mindfulness intervention during RT increases brain tumor patients' state mindfulness and whether the degree of changes in state mindfulness during RT predict decreases in acute anxiety and anxiety in daily life.

    Modified Metacognitive Processes of Decentering Scale (MPoD) consists of 4 items scored on a 0-10 scale, "0" meaning "Not at All" and "10" meaning "Very Much".

  3. Change in self transcendence and the magnitude/degree of change in self transcendence as measured by total score of the Nondual Awareness Dimensional Assessment (NADA.)

    Time frame: 7 weeks

    To determine whether the brief mindfulness intervention during RT increases brain tumor patients' self transcendence and whether the degree of changes in self transcendence during RT predict decreases in anxiety in daily life.

Study contacts

Contact information is provided by the study sponsor or research team.

Rachel Kingsford

CONTACT

[email protected]

801-585-0115

Sponsors and collaborators

Lead sponsor

University of Utah

Other

Registry information

Official study title

An Interventional Trial Using Guided Meditation During Radiation Therapy for Brain Tumors

Acronym: Med-RT

Important dates

Study start
2024
Primary completion
2027
Study completion
2028
First posted
Dec 11, 2023
Registry last updated
Mar 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.